Carbenoxolone disodium

Overview

Carbenoxolone disodium is the active metabolite of Glycyrrhizic acid ( HY-N0184 ) and the inhibitor of human 11β-HSD and bacterial 3α, 20β-HSD . Carbenoxolone disodium is an uncoupling agent for gap junctions and a potent inhibitor of Vaccinia virus replication. Carbenoxolone disodium is used for the study of peptic, esophageal and oral ulceration and inflammation. Carbenoxolone disodium inhibits Vaccinia virus replication.

Application

Products | Products > Disease Areas > Viral Infection | Products > Disease Areas > Bacterial Infection | Products > Disease Areas > Orthopoxvirus Infection | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > Gap Junction Protein | Products > Signaling Pathways > Orthopoxvirus | Products > Signaling Pathways > 11β-HSD

Product Information

• Catalog No.: HY-B1367
• CAS No.: 7421-40-1
• Molecular Formula: C34H48Na2O7
• Molecular Weight: 614.72
• Purity: 99.94%
• Storage: -20°C, sealed storage, away from moisture * In solvent : -80°C, 1 year; -20°C, 6 months (sealed storage, away from moisture)
• Solubility: ≥ 1.25 mg/mL (2.03 mM); Clear solution
• Availability: In-stock

Source

Original product source